About Inclinix
Inclinix is a Healthcare company based in Wilmington (United States) founded in 1999, and was acquired by PMG Research in June 2012. Customized solutions for clinical trial enrollment are provided. Inclinix has raised $10.5 million across 2 funding rounds from investors including PMG Research and Frontier Capital. Inclinix has completed 1 acquisition, including PMG Research. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Elligo, Acurian and CenExel; 2 of its 3 listed competitors have raised funding.
Company details
Inclinix, established in 1999, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, functional services, and research site and patient recruitment. Customized clinical trial enrollment solution. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Wilmington, United States
- Stage Acquired
- SectorsHealthcare
- Website inclinix.com
- Social LinkedIn X
- Acquired by PMG Research (Jun 2012)
- Total Equity Funding$10.5M (USD)
in 2 rounds
- Latest Funding Round$500K (USD), Series B
Sep 2010
- InvestorsPMG Research
& 1 more
- Investments & Acquisitions
- Acquired byPMG Research
(Jun 2012)
Funding Insights of Inclinix
Inclinix has successfully raised a total of $10.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $500 thousand completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.5M
- Total Rounds 2
- Last Round Series B — $500,000
- First Round $10M
(Jan 2008)
- Investors Count 1
All 2 funding rounds of Inclinix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2010 | $500,000 | Series B | – | – | – |
| Jan 2008 | $10M | Series B | – | Frontier Capital | – |
2 investors in total: 2 institutional.
Investors in Inclinix
Inclinix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include PMG Research and Frontier Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| frontiercapital.com | ||||
Integrated network of clinical research facilities | 1979 | pmg-research.com | Winston-salem, United States |
Investor details for Inclinix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Inclinix
Inclinix has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PMG Research.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Integrated network of clinical research facilities | pmg-research.com | Winston-salem, United States | 1979 | Jun 2012 | •••• |
Complete acquisition details for Inclinix
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Inclinix
5 dated milestones of Inclinix across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Inclinix is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series B, of $500K.
- Acquisition Acquires PMG Research.
- Exit Acquired by PMG Research.
Competitors of Inclinix
Inclinix has 3 listed competitors in our database, 2 of them funded. They include Elligo, Acurian and CenExel.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elligohealthresearch.com | 2016 | Austin, United States | $176.48M | 280 | Patient recruitment and site activation services are provided by Elligo. | |
| acurian.com | 1998 | Horsham, United States | $27M | Patient enrollment and retention solutions for clinical trials are offered. | ||
| cenexelresearch.com | 2019 | Salt Lake, United States | 451 | Research site management and patient recruitment services are provided. |
Detailed competitors of Inclinix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Inclinix (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Inclinix
Complete news archive for Inclinix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Inclinix
Inclinix was founded in 1999 and raised its 1st funding round 9 years after it was founded.
Inclinix is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Inclinix is a funded company, having raised a total of $10.5M across 2 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Jan 2008.
Inclinix, established in 1999, excels in providing healthcare solutions, biopharma outsourcing, cro, clinical development, functional services, and research site and patient recruitment. Customized clinical trial enrollment solution. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Inclinix has made 1 acquisition, including PMG Research.
Inclinix has 2 investors. Key investors include PMG Research, and Frontier Capital.
Yes. Inclinix was acquired by PMG Research in June 2012.